According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents. Rising research activities on contrast agents & their applications are the key areas of opportunity in this market
GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).
Recent Developments:
> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.
> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.
> In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.
Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media. In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry. The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.
Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast agent market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.
North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast media market study. North American market is expected to account for the largest share of the global Contrast Media Contrast Agent Market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
Contrast Media Contrast Agent Market Recent Developments - Industry Report 2024
The Global Contrast Media Injectors Market report encompasses vital information about the Contrast Media Injectors market that offers valuable insights about the dynamics of the Contrast Media Injectors market to the readers and businesses.
The report presents key statistical data about the Contrast Media Injectors market for the forecast timeline of 2020-2027, covering historical analysis, demands and supply dynamics, current and emerging trends, and revenue estimations.
The report consists of total market insight based on the company, major countries, and applications and types in the competitive market.
The report strives to provide an accurate estimation of the market trends for the Contrast Media Injectors market from the year 2020 to the year 2027.
The research report consists of a complete market analysis, including financial standing, revenue estimation, limitations, and dynamics that might affect the market.The report is generated according to the latest economic landscape in tune with the COVID-19 crisis.
The pandemic has affected the global economic scenario, and the report provides details about its impact on the overall industry.
According to research report the global contrast media market is expected to reach USD 8.68 billion by 2027 from USD 4.56 billion in 2018, at a CAGR of 3.9%.
The major factors driving the growth of the contrast media/contrast agents market include increasing number of research and funding activities for research of contrast agents and their applications.
Please share your specific interest to serve you better: Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 North America to dominate the market in 2017 North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the regions considered for a geographic analysis of the global contrast media/contrast agents market.
However, the Asia Pacific contrast media/contrast agents market is expected to grow at the highest CAGR in the forecast period.
This growth can be attributed to the increasing R investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries.
The prominent players in the global contrast media/contrast agents market include GE Healthcare (US), Bracco Imaging S.p.A. (Bracco) (Italy), Bayer HealthCare (Bayer) (Germany), and Guerbet Group (Guerbet) (France).
The global contrast media market size is expected to reach USD 6.9 billion by 2027, exhibiting a CAGR of 3.6% during the forecast period, according to a new report published by Radiant Insights, Inc. Increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel the contrast agents market growth.
The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and x-rays have become an inevitable part of diagnosis for most of the diseases.
Also, the safety of contrast agents for clinical use is under strict scrutiny.
Download Free Sample Report @ https://www.radiantinsights.com/research/contrast-media-market/request-sample The rapid rise in the use of medical imaging during the last few decades has resulted in a substantial increase in the use of radiologic contrast media.
Half of the around 76.0 million computed tomographic and 34.0 million magnetic resonance imaging examinations performed annually include the use of intravenous contrast agents.
Further key findings from the report suggest: • Iodinated contrast media was the largest segment in 2019 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity • X-ray/ CT was the largest modality segment in 2019, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques • Cardiovascular diseases is projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/ CT contrast agents in U.S. For instance, in 2016, the U.S. FDA approved Lumason for use in liver ultrasonography • North America dominated the contrast media/contrast agents market with the largest revenue share of 44.3% in 2019 owing to the presence of well-established healthcare infrastructure and availability of advanced technology • Some of the key players operating in the market are Bayer AG; General Electric Company; Guerbet; Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; Trivitron Healthcare; nano Therapeutics Pvt.
Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market.
However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.The report Contrast Media Injectors Market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959The consumables segment accounted for the largest share of the contrast media injection market, by type, in 2019.Based on the product, the contrast media injectors market is segmented into injector systems, consumables, and accessories.
The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors.
In 2019, the consumables segment accounted for the largest share of the contrast media injectors market.
The large share of this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures.
These consumables need to be re-purchased for every new procedure, as opposed to instruments, thus driving its demand.The interventional cardiology segment to register the highest CAGR in the contrast media injector market during the forecast period.Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the ct contrast media market include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Sanochemia, Tyco Healthcare, and Imax.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global CT Contrast Media Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/ct-contrast-media-market/download-sampleMarket DynamicsA computed tomography (CT) scan is a broadly recognized medical imaging technique worldwide to get detailed internal body structure images for diagnostic purposes.
CT scan offers several advantages over other imaging techniques.
The key factors estimated to steer the growth of the CT contrast media market are the growing need for effective and early diagnosis, the rising global prevalence of targeted diseases, increasing preference for minimally invasive diagnostic procedures, an aging population, and benefits of CT scans over other imaging modalities.
However, the choice for other imaging diagnostic techniques over CT, such as magnetic resonance imaging (MRI) and X-radiation (x-ray), limits the demand for CT contrast media.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
The Contrast Media Agents Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the contrast media agents market include Bayer AG, Bracco Diagnostics, Inc., General Electric Company, Guerbet, Lantheus Medical Imaging, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Contrast Media Agents Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/contrast-media-agents-market/download-sampleMarket DynamicsThe rising prevalence of cardiovascular and musculoskeletal disorder coupled with an increasing geriatric population is propelling the market growth of contrast media agents.
Additionally, ongoing technological advancements in diagnostic imaging coupled with utilization of contrast agents are further pushing the market demand.
The latest trending report Global Contrast Media Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Contrast Media industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Contrast Media and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/41859-contrast-media-contrast-agents-industry-analysis-reportThe major players covered in Contrast Media are:GEBeiLu PharmaGuerbet GroupBayerYRPGBracco ImagingLantheusHengrui MedicineBy Type, Contrast Media market has been segmented intoX-ray & CT Contrast MediaMRI Contrast MediaUltrasound Contrast MediaBy Application, Contrast Media has been segmented into:HospitalsClinicsThe report offers in-depth assessment of the growth and other aspects of the Contrast Media market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Contrast Media Market @ https://www.decisiondatabases.com/contact/download-sample-41859The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Contrast Media product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Contrast Media, with price, sales, revenue and global market share of Contrast Media in 2018 and 2019.Chapter 3, the Contrast Media competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Contrast Media breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Contrast Media market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Contrast Media sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Contrast Media Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-41859Other Reports by DecisionDatabases.com:Global Cell Culture Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024Global Filter Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024Global Stem Cell Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
The Global Contrast Media Injectors Market report encompasses vital information about the Contrast Media Injectors market that offers valuable insights about the dynamics of the Contrast Media Injectors market to the readers and businesses.
The report presents key statistical data about the Contrast Media Injectors market for the forecast timeline of 2020-2027, covering historical analysis, demands and supply dynamics, current and emerging trends, and revenue estimations.
The report consists of total market insight based on the company, major countries, and applications and types in the competitive market.
The report strives to provide an accurate estimation of the market trends for the Contrast Media Injectors market from the year 2020 to the year 2027.
The research report consists of a complete market analysis, including financial standing, revenue estimation, limitations, and dynamics that might affect the market.The report is generated according to the latest economic landscape in tune with the COVID-19 crisis.
The pandemic has affected the global economic scenario, and the report provides details about its impact on the overall industry.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the ct contrast media market include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma, Sanochemia, Tyco Healthcare, and Imax.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global CT Contrast Media Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/ct-contrast-media-market/download-sampleMarket DynamicsA computed tomography (CT) scan is a broadly recognized medical imaging technique worldwide to get detailed internal body structure images for diagnostic purposes.
CT scan offers several advantages over other imaging techniques.
The key factors estimated to steer the growth of the CT contrast media market are the growing need for effective and early diagnosis, the rising global prevalence of targeted diseases, increasing preference for minimally invasive diagnostic procedures, an aging population, and benefits of CT scans over other imaging modalities.
However, the choice for other imaging diagnostic techniques over CT, such as magnetic resonance imaging (MRI) and X-radiation (x-ray), limits the demand for CT contrast media.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
According to research report the global contrast media market is expected to reach USD 8.68 billion by 2027 from USD 4.56 billion in 2018, at a CAGR of 3.9%.
The major factors driving the growth of the contrast media/contrast agents market include increasing number of research and funding activities for research of contrast agents and their applications.
Please share your specific interest to serve you better: Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 North America to dominate the market in 2017 North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the regions considered for a geographic analysis of the global contrast media/contrast agents market.
However, the Asia Pacific contrast media/contrast agents market is expected to grow at the highest CAGR in the forecast period.
This growth can be attributed to the increasing R investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries.
The prominent players in the global contrast media/contrast agents market include GE Healthcare (US), Bracco Imaging S.p.A. (Bracco) (Italy), Bayer HealthCare (Bayer) (Germany), and Guerbet Group (Guerbet) (France).
The Contrast Media Agents Market 2021 research report gives emerging industry data, global segments and regional outlook.
This report covers up all details such as size, share, value, growth, restraints, and opportunities for the year 2020 to 2027.
The report generated using various analysis tools like porter’s five forces model, market attractiveness and value chain.
The report gives comprehensive review of the global market helping to club revenue generation and profitable business to transform client’s success.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the contrast media agents market include Bayer AG, Bracco Diagnostics, Inc., General Electric Company, Guerbet, Lantheus Medical Imaging, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Contrast Media Agents Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/contrast-media-agents-market/download-sampleMarket DynamicsThe rising prevalence of cardiovascular and musculoskeletal disorder coupled with an increasing geriatric population is propelling the market growth of contrast media agents.
Additionally, ongoing technological advancements in diagnostic imaging coupled with utilization of contrast agents are further pushing the market demand.
The global contrast media market size is expected to reach USD 6.9 billion by 2027, exhibiting a CAGR of 3.6% during the forecast period, according to a new report published by Radiant Insights, Inc. Increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel the contrast agents market growth.
The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and x-rays have become an inevitable part of diagnosis for most of the diseases.
Also, the safety of contrast agents for clinical use is under strict scrutiny.
Download Free Sample Report @ https://www.radiantinsights.com/research/contrast-media-market/request-sample The rapid rise in the use of medical imaging during the last few decades has resulted in a substantial increase in the use of radiologic contrast media.
Half of the around 76.0 million computed tomographic and 34.0 million magnetic resonance imaging examinations performed annually include the use of intravenous contrast agents.
Further key findings from the report suggest: • Iodinated contrast media was the largest segment in 2019 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity • X-ray/ CT was the largest modality segment in 2019, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques • Cardiovascular diseases is projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/ CT contrast agents in U.S. For instance, in 2016, the U.S. FDA approved Lumason for use in liver ultrasonography • North America dominated the contrast media/contrast agents market with the largest revenue share of 44.3% in 2019 owing to the presence of well-established healthcare infrastructure and availability of advanced technology • Some of the key players operating in the market are Bayer AG; General Electric Company; Guerbet; Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; Trivitron Healthcare; nano Therapeutics Pvt.
The latest trending report Global Contrast Media Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Contrast Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Contrast Media industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Contrast Media and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/41859-contrast-media-contrast-agents-industry-analysis-reportThe major players covered in Contrast Media are:GEBeiLu PharmaGuerbet GroupBayerYRPGBracco ImagingLantheusHengrui MedicineBy Type, Contrast Media market has been segmented intoX-ray & CT Contrast MediaMRI Contrast MediaUltrasound Contrast MediaBy Application, Contrast Media has been segmented into:HospitalsClinicsThe report offers in-depth assessment of the growth and other aspects of the Contrast Media market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Contrast Media Market @ https://www.decisiondatabases.com/contact/download-sample-41859The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Contrast Media product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Contrast Media, with price, sales, revenue and global market share of Contrast Media in 2018 and 2019.Chapter 3, the Contrast Media competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Contrast Media breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Contrast Media market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Contrast Media sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Contrast Media Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-41859Other Reports by DecisionDatabases.com:Global Cell Culture Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024Global Filter Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024Global Stem Cell Media Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market.
However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.The report Contrast Media Injectors Market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959The consumables segment accounted for the largest share of the contrast media injection market, by type, in 2019.Based on the product, the contrast media injectors market is segmented into injector systems, consumables, and accessories.
The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors.
In 2019, the consumables segment accounted for the largest share of the contrast media injectors market.
The large share of this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures.
These consumables need to be re-purchased for every new procedure, as opposed to instruments, thus driving its demand.The interventional cardiology segment to register the highest CAGR in the contrast media injector market during the forecast period.Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology.